We are pleased to announce the upcoming conference hosted by the Eira Initiative in association with the Berkeley Policy Institute:
🔬 Competing for the Cure: Intellectual Property, Innovation Policy, and Biopharmaceutical Ecosystems
📅 Date: October 29–30, 2026
📍 Location: Maison de l'Amérique Latine, Paris
This year's program moves beyond general frameworks to dive deep into cutting-edge, empirical research shaping the global biopharmaceutical and medical-device sectors.
🌟 Featured Highlights & Panels:
Opening & Keynote Remarks: Featuring insights from Jonathan Barnett (University of Southern California) , Margaret Kyle (Mines Paris - PSL, CEDP) , and a Keynote Lunch Address by Mark Schankerman (London School of Economics).
Global Ecosystems & Trade: Deep dives into the emerging transformation of European life sciences , India's biopharmaceutical industry two decades after WTO-TRIPS , and a strategic look at Chinese industrial and patent policy.
Price Controls & Market Dynamics: Quantifiable evidence evaluating how European price control regimes affect U.S. pharmaceutical innovation , alongside comparative analyses of pricing systems in Japan.
AI & Exclusivity Rights: Navigating the critical doctrinal shifts introduced by autonomous AI in drug discovery, including human inventorship requirements and sufficiency of disclosure.
Crisis-Driven Innovation: Examining newly assembled empirical data on how localized health outbreaks (such as SARS, MERS, and H1N1) fuel high-impact pharmaceutical innovation.
Fireside Chat: An exclusive policy discussion featuring Kamil Kiljanski (European Commission) and Nicolas Petit (European University Institute), moderated by Bowman Heiden (Gothenburg University, UC Berkeley).
By bringing together rigorous quantitative, qualitative, and legal analysis from a global network of leading scholars, this event provides the trustworthy, empirical data needed to inform future public policy.
👉 Explore the full 2026 conference program, research panels, and abstracts here.
Registration here.